Industry Veteran to Lead Waters Efforts to Serve the Needs of Toxicology, Forensics, and Clinical Laboratories

Waters Corporation (NYSE:WAT) today announced the appointment of Mark Bruns, Ph.D. to the position of Senior Director Clinical Business Operations, Waters Division. Bruns, 42, joins Waters from Abbott Diagnostics where he was responsible for Global Marketing for Abbott’s infectious disease business and, in his last role at Abbott, was Director of Business Development for Abbott’s $2.8B Diagnostics Division. Bruns earned his Ph.D. in chemistry in 1990 from the University of Illinois, Urbana-Champaign.

For almost 20 years, Waters products for the clinical laboratory have enabled laboratories to solve challenging analytical problems. Waters MassTrak™ integrated system solutions, incorporating liquid chromatography, mass spectrometry, analytical column chemistries, software and test kits, continue to meet the needs of clinical laboratories, transplant hospitals and reference laboratories in the areas of therapeutic drug monitoring, disease management, endocrinology, and toxicology.

About Waters Corporation (www.waters.com)

Waters Corporation creates business advantage for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.58 billion in 2008 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.